Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma

GOALS AND BACKGROUND: Clinical staging with endoscopic ultrasound (EUS) and positron emission tomography (PET) is used to identify esophageal adenocarcinoma (EAC) patients with locally advanced disease and therefore, benefit from neoadjuvant therapy. However, EUS is operator dependent and subject to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Gastroenterol
Autors principals: Thota, Prashanthi N., Alkhayyat, Motasem, Cifuentes, Juan David Gomez, Haider, Mahnur, Bena, James, McMichael, John, Sohal, Davender P, Raja, Siva, Sanaka, Madhusudhan R.
Format: Artigo
Idioma:Inglês
Publicat: 2022
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255331/
https://ncbi.nlm.nih.gov/pubmed/33405434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001489
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars